Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Asthma is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm. Common symptoms include wheezing, coughing, chest tightness, and shortness of breath. Asthma is a disease affecting the airways that carry air to and from your lungs. People who suffer from this chronic condition are said to be asthmatic.
As per available reports about 13 Relevant journals, 16 Conferences, 18 Workshopsare presently dedicated exclusively to breathing disorder and about 684 articles are being published on Asthma.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance
According to World Health Organization (WHO) estimates 235 million people worldwide suffer from asthma. Asthma is the most common chronic disease among children. Asthma is not just a public health problem for high income countries: it occurs in all countries regardless of level of development. Over 80% of asthma deaths occur in low- and lower-middle income countries. Asthma is under-diagnosed and under-treated, creating a substantial burden to individuals and families and possibly restricting individuals’ activities for a lifetime.
Asthma is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm . Common symptoms include wheezing, coughing, chest tightness, and shortness of breath. Asthma is a disease affecting the airways that carry air to and from your lungs. People who suffer from this chronic condition are said to be asthmatic. The inside walls of an asthmatic's airways are swollen or inflamed. This swelling or inflammation makes the airways extremely sensitive to irritations and increases your susceptibility to an allergic reaction. As inflammation causes the airways to become narrower, less air can pass through them, both to and from the lungs. Symptoms of the narrowing include wheezing (a hissing sound while breathing), chest tightness, breathing problems, and coughing. Asthmatics usually experience these symptoms most frequently during the night and the early morning. Asthma is thought to be caused by a combination of genetic and environmental factors. Its diagnosis is usually based on the pattern of symptoms, response to therapy over time. It is clinically classified according to the frequency of symptoms, forced expiratory volume in one second (FEV1), and peak expiratory flow rate. Asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic) where atopy refers to a predisposition toward developing type 1 hypersensitivity reactions. Treatment of acute symptoms is usually with an inhaled short-acting beta-2 agonist (such as salbutamol) and oral corticosteroids. In very severe cases, intravenous corticosteroids, magnesium sulfate, and hospitalization may be required. Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by the use of inhaled corticosteroids. Long-acting beta agonists (LABA) or leukotriene antagonists may be used in addition to inhaled corticosteroids if asthma symptoms remain uncontrolled. The occurrence of asthma has increased significantly since the 1970s. In 2011, 235–300 million people globally have been diagnosed with asthma, and it caused 250,000 deaths. Asthma is an incurable illness. However, with good treatment and management an asthma patient can live a normal and active life. An asthma episode, or an asthma attack, is when symptoms are worse than usual. They can come on suddenly and can be mild, moderate or severe. Asthma affects people of all ages, but it most often starts during childhood. In the United States, more than 25 million people are known to have asthma and about 7 million of these people are children. About 2 conferences in UK, 1 in USA, 1 in Korea related to asthma will be organized recently.
Market Analysis
The United Kingdom respiratory care market, Based on anatomical features, the respiratory system is segmented into upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises pharynx, larynx, and nasal passages, while the lower respiratory tract includes trachea, lungs, and bronchi. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. Moreover, growing geriatric population and technological advancements would drive the globalrespiratory disease testing market. However, low adoption rate of digital radiography and portable spirometers are projected to hold back the growth of respiratory disease testing market from 2014 to 2022. The global respiratory disease testing market was valued at USD 2,326.5 million in 2013 and is estimated to reach USD 3,143.3 million in 2022, expanding at a CAGR of 3.4% from 2014 to 2022. For instance, the Centers for Disease Control and Prevention (CDC) published in 2012 that around 18.7 million adults in the U.K. were suffering from asthma. The American Lung Association states that COPD is the third leading cause of death in the U.K.
List of International Conferences
List of Societies and Associations
List of Companies and retreat centers
This page will be updated regularly.
This page was last updated on November 5, 2024
